Drug Discovery & Development Cover Story Features PointCross

Drug Discovery & Development interviewed us for this month's cover story written by James Netterwald, PhD, titled, "Keeping Pace, Keeping Track"

Here is an excerpt from the article, or read the entire article here:

Pharmaceutical companies have difficulty in performing comparative analyses across their entire knowledge base because preclinical data is often sitting in disperse systems and in disperse formats. "We offer a number of search and orienteering solutions, and business process automation, all built on top of our Orchestra platform," says Suresh Madhavan, PhD, founder and chief executive officer of PointCross, Foster City, Calif. For example, two systems built upon Orchestra are semantic data exchanger (SDE) and safety data integration (SDI). "SDI solution puts all available preclinical studies into a common universal operational data model with normalization, and with unit and taxonomy harmonization," says Madhavan, who adds that they also use a number of statistical techniques to extract layers of metadata from the raw data and pre-index them for rapid search. Following extraction, SDI then "allows researchers and study team members to navigate, search, and compare metadata across studies to discover patterns and correlations within the datasets." Ultimately, these technologies perform such analyses to support early safety screening.

According to Shree Nath, PhD, vice president of pharmaceuticals at PointCross, there is also an increasing need by their pharma clients to… Continue reading >

Learn More

• Register for our webinar on Cross-Study Search & Meta-Analysis for Safety Data on March 31st
• See our Safety Data Integration & Search (SDIS™) solution in action
• Join us for our session on "Early Safety Assessments Through Semantically Relevant Search & Data Exchange" at ToxExpo March 8th-10th
• Join us for our panel presentation with the FDA at DIA/FDA's Annual Meeting on March 22nd-23rd

Contact
For more information on SDIS™ and our other solutions for pharma, contact:
Dr. Shree Nath,
VP of Pharmaceuticals
E-mail:
or call us at +1 (650) 350-1900

Goto Top